REFERÊNCIAS
1. Banerjee A, Fowkes FG, Rothwell PM. Associations between peripheral artery disease and ischemic stroke: implications for primary and secondary prevention. Stroke. 2010;41(9):2102-7.
2. Criqui MH, Ninomiya JK, Wingard DL, Ji M, Fronek A. Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality. J Am Coll Cardiol. 2008;52(21):1736-42.
3. Liu Y, Chen K-J. Atherosclerosis, vascular aging and therapeutic strategies. Chin J Integr Med. 2012;18(2):83-7.
4. Lederle FA, Johnson GR, Wilson SE, Chute EP, Littooy FN, Bandyk D, et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med. 1997;126(6):441-9.
5. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop
Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol.
2006;47(6):1239-312.
6. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011;124(18):2020-45.
7. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;3(3 Suppl 1):S1-75.
8. Bozkurt AK, Tasci I, Tabak O, Gumus M, Kaplan Y. Peripheral artery disease assessed by ankle-brachial index in patients with established cardiovascular disease or at least one risk factor for atherothrombosis: CAREFUL Study: a national, multi-center, cross-sectional observational study. BMC Cardiovasc Disord. 2011;11:4.
9. Fowkes FGR, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300(2):197-208.
10. Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71-86.
11. Wind J, Koelemay MJW. Exercise therapy and the additional effect of supervision on exercise therapy in patients with intermittent claudication. Systematic review of randomised controlled trials. Eur J Vasc Endovasc Surg. 2007;34(1):1-9.
12. Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2008;(4):CD000990.
13. McDermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci L, Liu K, et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA.
2009;301(2):165-74.
14. Robless P, Mikhailidis DP, Stansby GP. Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev. 2008;(1):CD003748.
15. Wong PF, Chong LY, Mikhailidis DP, Robless P, Stansby G. Antiplatelet agents for intermittent claudication. Cochrane Database Syst Rev. 2011;11:CD001272.
16. Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA. 2009;301(18):1909-19.
17. Kasapis C, Gurm HS. Current approach to the diagnosis and treatment of femoral-popliteal arterial disease: a systematic review. Curr Cardiol Rev. 2009;5(4):296-311. 18. Kiernan TJ, Hynes BG, Ruggiero NJ, Yan BP, Jaff MR. Comprehensive evaluation and medical management of infrainguinal peripheral artery disease: “when to treat, when not to treat.” Tech Vasc Interv Radiol. 2010;13(1):2-10.
19. Shea KW. Antimicrobial therapy for diabetic foot infections: a practical approach. Postgrad Med. 1999;106(1):85-86, 89-94.
20. Temple ME, Nahata MC. Pharmacotherapy of lower limb diabetic ulcers. J Am Geriatr Soc. 2000;48(7):822-8.
21. Sader HS, Durazzo A. Antimicrobial therapy in diabetic foot infections. J Vasc Br. 2003;2(1):61-6.
22. Working Party on Thrombolysis in the Management of Limb Ischemia. Thrombolysis in the management of lower limb peripheral arterial occlusion: a consensus document. Am J Cardiol. 1998;81(2):207-18.
23. Rose WM 3rd, Ernst CB. Abdominal aortic aneurysm. Compr Ther. 1995;21(7):339-43.
24. Perler BA. The management of patients with ruptured abdominal aortic aneurysms. Adv Surg. 1996;30:21-38.
25. Baxter BT, McGee GS, Flinn WR, McCarthy WJ, Pearce WH, Yao JS. Distal embolization as a presenting symptom of aortic aneurysms. Am J Surg.
1990;160(2):197-201.
26. Ernst CB. Abdominal aortic aneurysm. N Engl J Med. 1993;328(16):1167-72. 27. Chaikof EL, Brewster DC, Dalman RL, Makaroun MS, Illig KA, Sicard GA, et al. The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines. J Vasc Surg. 2009;50(4 Suppl):S2-49.
28. Katz DA, Littenberg B, Cronenwett JL. Management of small abdominal aortic aneurysms: early surgery vs watchful waiting. JAMA. 1992;268(19):2678-86.
29. Moore WS, Rutherford RB. Transfemoral endovascular repair of abdominal aortic aneurysm: results of the North American EVT phase 1 trial. EVT Investigators. J Vasc Surg. 1996;23(4):543-53.
30. Pereira AH, Sanvitto PC, Souza GG. Exclusion of AAA by aorto uni-iliac endografts. Int Angiol. 2000;19(1):70-9.
31. Pereira AH, Sanvitto PC, de Souza GG, Costa LF, Grudtner MA. Aortomonoiliac stent-grafts for abdominal aortic aneurysm repair: association with iliofemoral crossover grafts. J Endovasc Ther. 2002;9(6):765-71.
32. Vrijenhoek JEP, Mackaay AJC, Cornelissen SAP, Moll FL. Long-term outcome of popliteal artery aneurysms after ligation and bypass. Vasc Endovascular Surg.
2011;45(7):604-6.
33. Bowrey DJ, Osman H, Gibbons CP, Blackett RL. Atherosclerotic popliteal
aneurysms: management and outcome in forty-six patients. Eur J Vasc Endovasc Surg. 2003;25(1):79-81.
34. LeRoy EC, Medsger TA Jr. Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol. 1992;10(5):485-8.
35. Wigley FM. Clinical practice. Raynaud’s phenomenon. N Engl J Med. 2002;347(13):1001-8.
36. Thompson AE, Pope JE. Calcium channel blockers for primary Raynaud’s phenomenon: a meta-analysis. Rheumatology (Oxford). 2005;44(2):145-50. 37. Vinjar B, Stewart M. Oral vasodilators for primary Raynaud’s phenomenon. Cochrane Database Syst Rev. 2008;(2):CD006687.
38. Funauchi M, Kishimoto K, Shimazu H, Nagare Y, Hino S, Yano T, et al. Effects of bosentan on the skin lesions: an observational study from a single center in Japan. Rheumatol Int. 2009;29(7):769-75.
39. Nguyen VA, Eisendle K, Gruber I, Hugl B, Reider D, Reider N. Effect of the dual endothelin receptor antagonist bosentan on Raynaud’s phenomenon secondary to
systemic sclerosis: a double-blind prospective, randomized, placebo-controlled pilot study. Rheumatology (Oxford). 2010;49(3):583-7.
40. Rosato E, Molinaro I, Borghese F, Rossi C, Pisarri S, Salsano F. Bosentan improves skin perfusion of hands in patients with systemic sclerosis with pulmonary arterial hypertension. J Rheumatol. 2010;37(12):2531-9.
41. Naldi L, Locati F, Marchesi L, Cortelazzo S, Finazzi G, Galli M, et al. Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study. Ann Rheum Dis.
1993;52(3):219-22.
42. Dupont PJ, Lightstone L, Clutterbuck EJ, Gaskin G, Pusey CD, Cook T, et al. Lesson of the week: cholesterol emboli syndrome. BMJ. 2000;321(7268):1065-7.
LEITURAS RECOMENDADAS
Brito CJ, organizador. Cirurgia vascular, cirurgia endovascular e angiologia. 2. ed. Rio de Janeiro: Revinter; 2008.
Livro-texto nacional que discute a cirurgia vascular como um todo, não se limitando apenas a procedimentos cirúrgicos, mas também considerando a importância do diagnóstico clínico e dos vários métodos de imagem empregados na investigação das doenças vasculares periféricas.
Ernst CB, Stanley JC. Current therapy in vascular surgery. 4th ed. St. Louis: Mosby; 2001.
Revisão atual abrangendo discussão sobre diagnóstico e conduta em doenças vasculares periféricas.
Nectoux JL, Cunha SS, Paglioli S, Souza GG, Pereira AH. Doenças vasculares periféricas. Rio de Janeiro: Revinter; 1994.
Indicado para consulta rápida sobre métodos diagnósticos nas doenças vasculares periféricas.
Rutherford RB. Vascular surgery. 7th ed. Philadelphia: WB Saunders; 2010.
Trata-se de um dos principais livros-texto da especialidade. É recomendado ao leitor que necessita de informações sobre doenças não incluídas neste capítulo ou que deseja aprofundar-se em um tópico específico.
Wigley FM. Raynaud’s phenomenon. N Engl J Med. 2002;347:1001-8.
SITES RECOMENDADOS
Sociedade Brasileira de Angiologia e Cirurgia Vascular (SBACV). Disponível em: http://www.sbacv.com.br/.
Portal da sociedade, que oferece links para sociedades médicas, centros de pesquisa, educação e treinamento, publicações e outras fontes de informações médicas da área.
